Citizen Portal
Sign In

Get Full Government Meeting Transcripts, Videos, & Alerts Forever!

Get email alerts on the Ceo Performance Assessment topic

No spam. Unsubscribe anytime.

Hospital Authority committee approves FY26 CEO performance-assessment form and forwards it to full board

5724095 · July 31, 2025
AI-Generated Content: All content on this page was generated by AI to highlight key points from the meeting. For complete details and context, we recommend watching the full video. so we can fix them.

Summary

The Hospital Authority CEO Performance Review Committee approved a draft FY26 CEO performance-assessment form with edits—including a 0–5% bonus scale, a new technology-and-innovation metric, and a recommended compensation analysis—and voted to send the form to the full board for approval.

On July 31, the Hospital Authority CEO Performance Review Committee approved a draft performance-assessment form for the hospital CEO for fiscal year 2025–26 and voted to forward the form to the full board for final approval.

The committee approved the assessment form with several amendments, including clarifying the bonus range as 0% to 5% (which requires changing the scoring tranches from five to six), correcting the fiscal-year header to 2025–26, and adding a technology and innovation metric to the growth category. The committee chair said the form breaks CEO performance into five categories—growth, financial leadership, quality of care and customer service (a combined category), employee excellence, and board and stakeholder relationships—and that each category is scored on a 1-to-5 scale to determine a year-end bonus percentage from 0% to 5%.

The assessment also adds measurement criteria for quality and customer-service metrics and expands preventive health programs, specifically naming diabetes prevention and heart-health initiatives as targets. The committee included a new employee-excellence category that calls for a hospital-wide salary and compensation analysis and implementation of succession planning across the organization. The growth category was revised to include a technology-and-innovation plan and a requirement that capital and innovation purchases demonstrate an ROI and breakeven analysis to HAB.

Committee members thanked interim CEO Dr. Elders and others for contributing to the draft. The committee noted coordination with the Nashville General Hospital Foundation and said the foundation will be part of goal-setting and onboarding for new board members. The committee approved the minutes of the prior meeting earlier in the session and then approved the amended FY26 CEO performance-assessment form and voted to move it to the full Hospital Authority board for final approval.

The committee adjourned after the vote.